Narrow search
Showing 1 - 5 of 5
Cover Image
Public and private pharmaceutical spending as determinants of health outcomes in Canada
Crémieux, Pierre-Yves; Meilleur, Marie-Claude; … - In: Health economics 14 (2005) 2, pp. 107-116
Persistent link: https://www.econbiz.de/10002606319
Cover Image
A reply to "A second look at pharmaceutical spending as determinants of health outcomes in Canada"
Crémieux, Pierre-Yves; Meilleur, Marie-Claude; … - In: Health economics 21 (2012) 12, pp. 1496-1498
Persistent link: https://www.econbiz.de/10009690925
Cover Image
A response to Crémieux, Meilleur, Ouellette and Petit
Guindon, G. Emmanuel; Contoyannis, Paul - In: Health economics 21 (2012) 12, pp. 1499-1501
Persistent link: https://www.econbiz.de/10009690922
Cover Image
The Impact of Antihypertensive Drugs on the Number and Risk of Death, Stroke and Myocardial Infarction in the United States
Long, Genia; Cutler, David M.; Berndt, Ernst R.; Royer, … - 2021
Estimating the value of medical innovation is a continual challenge. In this research, we quantify the impact of antihypertensive therapy on U.S. blood pressures, risk and number of heart attacks, strokes, and deaths. We also consider the potential for further improvements. We estimate the value...
Persistent link: https://www.econbiz.de/10013218844
Cover Image
The Impact of Antihypertensive Drugs on the Number and Risk of Death, Stroke and Myocardial Infarction in the United States
Long, Genia - 2006
Estimating the value of medical innovation is a continual challenge. In this research, we quantify the impact of antihypertensive therapy on U.S. blood pressures, risk and number of heart attacks, strokes, and deaths. We also consider the potential for further improvements. We estimate the value...
Persistent link: https://www.econbiz.de/10012466572